Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
793.01
+2.36 (0.30%)
At close: Jul 11, 2025, 4:00 PM
792.00
-1.01 (-0.13%)
After-hours: Jul 11, 2025, 7:59 PM EDT

Eli Lilly Revenue

Eli Lilly had revenue of $12.73B in the quarter ending March 31, 2025, with 45.17% growth. This brings the company's revenue in the last twelve months to $49.00B, up 36.38% year-over-year. In the year 2024, Eli Lilly had annual revenue of $45.04B with 32.00% growth.

Revenue (ttm)
$49.00B
Revenue Growth
+36.38%
P/S Ratio
14.57
Revenue / Employee
$1,042,621
Employees
47,000
Market Cap
711.91B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 45.04B 10.92B 32.00%
Dec 31, 2023 34.12B 5.58B 19.56%
Dec 31, 2022 28.54B 223.00M 0.79%
Dec 31, 2021 28.32B 3.78B 15.40%
Dec 31, 2020 24.54B 2.22B 9.95%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 410.06B
Johnson & Johnson 89.33B
Merck & Co. 63.92B
AbbVie 57.37B
AstraZeneca 54.98B
Novartis AG 53.22B
Novo Nordisk 43.92B
Thermo Fisher Scientific 42.90B
Revenue Rankings